Investor Relations

MTG Biotherapeutics is a privately funded company dedicated to the development REIC expression technology for the treatment of various cancer indications. Founded in 2014, the company has moved the program quickly to bring this the novel therapy to oncology patients.

MTG Biotherapeutics is primarily focused on prostate cancer, methothelioma, bladder cancer and hepatocellular carcinoma where there are no or poorly effective therapy.

Contact us

Please submit your question using the form below.